Urology

The Bellmunt Risk Score accurately predicts survival in metastatic castration-resistant prostate cancer, supporting its use in guiding treatment and risk stratification.

Virtual reality may help reduce patient anxiety, by giving people a better understanding of upcoming medical procedures, researchers reported today at EAU26.

Researchers reveal what matters most to patients with prostate cancer in treatment decisions at the Annual Congress of the European Association of Urology 2026.

With AI decision support, basic readers achieved efficiency scores comparable to expert radiologists, suggesting that AI may help standardise prostate cancer diagnosis across different levels of clinical expertise.

EAU 2026 data show prostate cancer screening has minimal impact on men’s quality of life and health anxiety, helping fill a key evidence gap for screening policy.

Researchers compared prostate and breast cancer screening outcomes in Germany in a meta-analysis presented at the Annual Congress of the European Association of Urology 2026.

A new AI model has outperformed traditional methods of bladder cancer classification, yielding a 95.5% accuracy.

First-line treatments for erectile dysfunction are under-prescribed in patients with prostate cancer, despite favourable clinical outcomes.